Last reviewed · How we verify
Bisphonal (INCADRONIC ACID)
Bisphonal (generic name: INCADRONIC ACID) is a incadronic acid Small molecule drug developed by Astellas Pharma. It is currently FDA-approved for Humoral hypercalcemia of malignancy, Osteoporosis.
At a glance
| Generic name | INCADRONIC ACID |
|---|---|
| Sponsor | Astellas Pharma |
| Drug class | incadronic acid |
| Target | Farnesyl pyrophosphate synthase |
| Modality | Small molecule |
| Therapeutic area | Bone |
| Phase | FDA-approved |
Approved indications
- Humoral hypercalcemia of malignancy
- Osteoporosis
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bisphonal CI brief — competitive landscape report
- Bisphonal updates RSS · CI watch RSS
- Astellas Pharma portfolio CI
Frequently asked questions about Bisphonal
What is Bisphonal?
Bisphonal (INCADRONIC ACID) is a incadronic acid drug developed by Astellas Pharma, indicated for Humoral hypercalcemia of malignancy, Osteoporosis.
What is Bisphonal used for?
Bisphonal is indicated for Humoral hypercalcemia of malignancy, Osteoporosis.
Who makes Bisphonal?
Bisphonal is developed and marketed by Astellas Pharma (see full Astellas Pharma pipeline at /company/astellas).
What is the generic name of Bisphonal?
INCADRONIC ACID is the generic (nonproprietary) name of Bisphonal.
What drug class is Bisphonal in?
Bisphonal belongs to the incadronic acid class. See all incadronic acid drugs at /class/incadronic-acid.
What development phase is Bisphonal in?
Bisphonal is FDA-approved (marketed).
What does Bisphonal target?
Bisphonal targets Farnesyl pyrophosphate synthase and is a incadronic acid.
Related
- Drug class: All incadronic acid drugs
- Target: All drugs targeting Farnesyl pyrophosphate synthase
- Manufacturer: Astellas Pharma — full pipeline
- Therapeutic area: All drugs in Bone
- Indication: Drugs for Humoral hypercalcemia of malignancy
- Indication: Drugs for Osteoporosis
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing